Matinas Biopharma Hl (MTNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Sales | 0 | 0 | 90 | 30 | 45 |
| Gross Profit | N/A | N/A | 90 | 30 | 45 |
| Operating Expenses | 4,167 | 2,954 | 3,495 | 4,151 | 4,676 |
| Operating Income | -4,167 | -2,954 | -3,405 | -4,121 | -4,631 |
| Other Income | 33 | 19 | -6 | 11 | 646 |
| Pre-tax Income | -4,133 | -2,936 | -3,411 | -4,110 | -3,985 |
| Net Income Continuous | -3,627 | -2,936 | -3,411 | -4,110 | -3,628 |
| Net Income | $-3,627 | $-2,936 | $-3,411 | $-4,110 | $-3,628 |
| EPS Basic Total Ops | -1.50 | -1.50 | -2.00 | -2.50 | -1.50 |
| EPS Basic Continuous Ops | -1.62 | -1.55 | -1.81 | -2.20 | -1.90 |
| EPS Diluted Total Ops | -1.50 | -1.50 | -2.00 | -2.50 | -1.50 |
| EPS Diluted Continuous Ops | -1.62 | -1.55 | -1.81 | -2.20 | -1.90 |
| EBITDA(a) | $-4,105 | $-2,898 | $-3,352 | $-4,074 | $-4,586 |